van den Boom Esther
SEC CIK 1603563 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TYRA | Tyra Biosciences, Inc. | CFO | 121.9K | — | — | 3 | 2021-09-17 | 2022-09-15 |
Most active insiders at TYRA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MORE ROBERT J | Dir | — | $5.25M |
| 2 | Bensen Daniel | Chief Discovery Off | — | $4.81M |
| 3 | KAPLAN GILLA | Dir | — | $528.5K |
| 4 | Verjee Rehan | Dir | $20.0K | — |
| 5 | Rueb Yuliya | VP, Fin (PAO) | — | — |
| 6 | Warner Douglas J | Chief Medical Off | — | — |
| 7 | Ashar Bhavesh | COO | — | — |
| 8 | Harris Todd | Pres, CEO, Dir | — | — |
| 9 | Fuhrman Alan | CFO | — | — |
van den Boom Esther made no open-market trades at TYRA in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-19 | 2022-09-15 | TYRA | Tyra Biosciences, Inc. | van den Boom Esther | CFO | A - Grant | $7.66 | +1,452 | 121.9K | +1% | +$11.1K | |
| D | 2022-09-08 | 2022-03-15 | TYRA | Tyra Biosciences, Inc. | van den Boom Esther | CFO | A - Grant | $8.53 | +1,800 | 120.4K | +2% | +$15.4K |
| DI | 2021-09-17 | 2021-09-17 | TYRA | Tyra Biosciences, Inc. | van den Boom Esther | CFO | C - Cnv Deriv | — | +21.3K | 21.3K | New | — |
Purchase Sale Sale after option exercise All abbreviations